Partner Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-27,957
| Closed | -$821K | – | 119 |
|
|
2018
Q3 | $821K | Buy |
27,957
+1,093
| +4% | +$32.1K | 0.63% | 61 |
|
|
2018
Q2 | $1.22M | Buy |
+26,864
| New | +$1.22M | 0.99% | 35 |
|
|
2017
Q4 | – | Sell |
-4,053
| Closed | -$334K | – | 91 |
|
|
2017
Q3 | $334K | Sell |
4,053
-2,551
| -39% | -$210K | 0.32% | 62 |
|
|
2017
Q2 | $618K | Sell |
6,604
-15,233
| -70% | -$1.43M | 0.83% | 42 |
|
|
2017
Q1 | $1.39M | Sell |
21,837
-3,772
| -15% | -$240K | 1.69% | 19 |
|
|
2016
Q4 | $1.14M | Buy |
25,609
+7,630
| +42% | +$339K | 1.51% | 20 |
|
|
2016
Q3 | $648K | Sell |
17,979
-13,427
| -43% | -$484K | 0.96% | 40 |
|
|
2016
Q2 | $431K | Sell |
31,406
-539
| -2% | -$7.4K | 0.71% | 39 |
|
|
2016
Q1 | $613K | Sell |
31,945
-3,355
| -10% | -$64.4K | 1% | 29 |
|
|
2015
Q4 | $1.24M | Sell |
35,300
-11,979
| -25% | -$419K | 2.03% | 17 |
|
|
2015
Q3 | $4.35M | Buy |
47,279
+305
| +0.6% | +$28K | 6.57% | 1 |
|
|
2015
Q2 | $4.13M | Buy |
46,974
+6,176
| +15% | +$543K | 5.8% | 1 |
|
|
2015
Q1 | $3.03M | Sell |
40,798
-23,454
| -37% | -$1.74M | 4.56% | 1 |
|
|
2014
Q4 | $3.6M | Buy |
64,252
+27,454
| +75% | +$1.54M | 1.47% | 27 |
|
|
2014
Q3 | $1.67M | Buy |
36,798
+20,084
| +120% | +$911K | 0.61% | 33 |
|
|
2014
Q2 | $692K | Sell |
16,714
-65,836
| -80% | -$2.73M | 0.14% | 51 |
|
|
2014
Q1 | $5.72M | Sell |
82,550
-118,067
| -59% | -$8.18M | 1.05% | 34 |
|
|
2013
Q4 | $12.1M | Buy |
200,617
+47,611
| +31% | +$2.87M | 2.74% | 15 |
|
|
2013
Q3 | $9.3M | Sell |
153,006
-1,972
| -1% | -$120K | 2.48% | 16 |
|
|
2013
Q2 | $10.4M | Buy |
+154,978
| New | +$10.4M | 2.35% | 15 |
|